[H]C12CC3(O)C(OC)C(O)C(OC(C)=O)(C1([H])C3OC(=O)c1ccccc1)C1([H])C(OC)C3([H])C4(COC)CN(CC)C1([H])C23C(OC)CC4O
Assay: DRUGMATRIX inhibits MAO-A using Kynuramine as substrate with a single protein target (Homologous). The assay is In vitro, with Binding as the type description and BTI-TN-5B1-4 as the cell type. Does the molecule work for this assay?